During the past decade, Centre de Recherche du Centre Hospitalier de l'Universite Laval conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre de Recherche du Centre Hospitalier de l'Universite Laval" #1 sponsor was "Children's Oncology Group" with 12 trials, followed by "Boehringer Ingelheim" with 6 trials sponsored, "Laval University" with 6 trials sponsored, "CHU de Quebec-Universite Laval" with 4 trials sponsored and "British Columbia Centre for Disease Control" with 4 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Recherche du Centre Hospitalier de l'Universite Laval" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Centers for Disease Control and Prevention" with 1 trials as a collaborator, "Centre de Recheche du Centre Hospitalier Université Laval" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Centre de Recherche du Centre Hospitalier de l'Universite Laval" are "Leukemia" (6 trials), "Bone Health" (2 trials), "Breast Neoplasms" (2 trials), "Diabetes Mellitus, Type 1" (2 trials) and "Influenza" (2 trials). Many other conditions were trialed in "Centre de Recherche du Centre Hospitalier de l'Universite Laval" in a lesser frequency.

Most popular intervention types in "Centre de Recherche du Centre Hospitalier de l'Universite Laval" are "Drug" (19 trials), "Biological" (11 trials), "Procedure" (5 trials), "Radiation" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (8 trials), "radiation therapy" (5 trials), "vincristine sulfate" (5 trials), "Placebo" (4 trials) and "cytarabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Centre de Recherche du Centre Hospitalier de l'Universite Laval" are 29 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre de Recherche du Centre Hospitalier de l'Universite Laval". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Centre de Recherche du Centre Hospitalier de l'Universite Laval, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre de Recherche du Centre Hospitalier de l'Universite Laval, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".